Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Urge incontinence

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    62 result(s) found for: Urge incontinence. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2005-006201-12 Sponsor Protocol Number: 003 Start Date*: 2007-01-10
    Sponsor Name:MERCK SHARP DOHME
    Full Title: A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group, Dose-Ranging Study of MK-0594 in Patients With Overactive Bladder
    Medical condition: overactove bladder
    Disease: Version SOC Term Classification Code Term Level
    6.1 10046494 PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-000559-38 Sponsor Protocol Number: BTXA2021 Start Date*: 2022-07-02
    Sponsor Name:Herlev and Gentofte University Hospital, Department of Obstetrics and Gynecology
    Full Title: The effect of intravesical Lidocaine solution versus placebo as anesthesia prior to intravesical injection of onabotulinum toxin A. A randomized, double-blind, placebo controlled cross-over study
    Medical condition: The effect of intravesical Lidocaine solution versus placebo on pain perception during intravesical injection of Onabotulinum toxin A.
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004857 10046495 Urge incontinence syndrome LLT
    21.1 100000004852 10002321 Anesthesia LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-001376-42 Sponsor Protocol Number: IC-01-02-5-009 Start Date*: 2021-10-27
    Sponsor Name:Innovacell AG
    Full Title: Skeletal muscle-derived cell implantation for the treatment of fecal incontinence: a phase III, randomized, controlled, double blind, two armed clinical study.
    Medical condition: Fecal incontinence
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004856 10016296 Fecal incontinence LLT
    20.0 100000004856 10055507 Fecal incontinence aggravated LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) FR (Trial now transitioned) IT (Trial now transitioned) BG (Trial now transitioned) AT (Ongoing) PL (Trial now transitioned) CZ (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2005-001936-59 Sponsor Protocol Number: 191622-077 Start Date*: 2005-07-30
    Sponsor Name:ALLERGAN LTD
    Full Title: A multicenter, double-blind, randomized, placebo-controlled, parallel-group, dose-response study of the safety and efficacy of a single treatment of BOTOX® (botulinum toxin type A) purified neuroto...
    Medical condition: Idiopathic overactive bladder (symptoms of frequency and urgency) with urinary incontinence.
    Disease: Version SOC Term Classification Code Term Level
    7.1 10059617 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002143-27 Sponsor Protocol Number: 1208.15 Start Date*: 2005-02-15
    Sponsor Name:Boehringer Ingelheim Austria GmbH
    Full Title: A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (...
    Medical condition: Urge Urinary Incontinence (UUI)
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-001116-31 Sponsor Protocol Number: ESCLIN-002/04 Start Date*: 2004-11-03
    Sponsor Name:Laboratorios Dr. Esteve S.A.
    Full Title: Multicentre, randomised, double-blind, parallel group confirmatory Phase III study to compare the efficacy and safety of cizolirtine citrate 300 mg bid (600 mg/d), cizolirtine citrate 400 mg bid (...
    Medical condition: Urge Urinary Incontinence
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-022121-15 Sponsor Protocol Number: 4618-008 Start Date*: 2011-04-12
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A 52-week Extension to: A Phase IIb Randomized, Placebo- and Active Comparator (Tolterodine)-Controlled, 2-Part Clinical Study of the Efficacy and Safety of MK-4618 in Patients with Overactive Bladder
    Medical condition: Overactive Bladder
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004857 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) GB (Completed) DK (Completed) AT (Completed) NO (Completed) PL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-004499-19 Sponsor Protocol Number: 0634-007 Start Date*: 2005-11-22
    Sponsor Name:Merck Sharp & Dohme Ireland (Human Health) Limited
    Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of L-000796568 in Postmenopausal Women With Overactive Bladder
    Medical condition: Overative Bladder
    Disease: Version SOC Term Classification Code Term Level
    8.0 10059617 LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-006526-34 Sponsor Protocol Number: BTXA2008 Start Date*: 2008-12-19
    Sponsor Name:Gynækologisk-obstetrisk afd. G, Glostrup Hospital
    Full Title: Intravesikal instillation af Botulinum toxin type A til patienter med urge urininkontinens
    Medical condition: Urge urinary incontinence
    Disease: Version SOC Term Classification Code Term Level
    9.1 10048335 Urinary incontinence aggravated LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-004307-30 Sponsor Protocol Number: IXA-CSP-001 Start Date*: 2017-03-30
    Sponsor Name:IXALTIS
    Full Title: A Double-Blind, Randomised, Placebo-Controlled, Parallel Group, Phase II, Dose Ranging Trial to Evaluate the Efficacy, Safety and Tolerability of oral Litoxetine 10mg, 20mg and 40mg Twice Daily (BI...
    Medical condition: Mixed Urinary Incontinence
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: PL (Completed) FR (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-004452-13 Sponsor Protocol Number: A6121127 Start Date*: 2005-12-16
    Sponsor Name:Pfizer Inc.
    Full Title: A Randomized, Double Blind, Placebo Controlled Detrol La "Add-On" To Alpha-Blocker Study in men with persistent Overactive Bladder symptoms of urinary frequency and urgency with/without urgency inc...
    Medical condition: Overactive Bladder in Men
    Disease: Version SOC Term Classification Code Term Level
    8.0 10020853 LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: SK (Completed) ES (Completed) DK (Completed) GB (Completed) SE (Completed) IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005009-41 Sponsor Protocol Number: 05WH25 Start Date*: 2006-01-11
    Sponsor Name:King's College Hospital
    Full Title: Warning Time and Patient-Selected Goals: A Placebo Controlled Randomised Double-Blind Pilot Study of the Efficacy of Transdermal Oxybutynin for the Treatment of Urgency and Urge Incontinence.
    Medical condition: Overactive bladder.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004126-24 Sponsor Protocol Number: DRI6271 Start Date*: 2007-12-12
    Sponsor Name:sanofi-aventis recherche & développement
    Full Title: A placebo controlled randomized, 12-week, dose-ranging, double-blind study versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in women with overac...
    Medical condition: Overactive bladder including urge urinary incontinence
    Disease: Version SOC Term Classification Code Term Level
    10.0 10059617 LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: CZ (Completed) PT (Completed) FR (Completed) NL (Prematurely Ended) DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-001119-69 Sponsor Protocol Number: ESCLIN-003/04 Start Date*: 2004-11-03
    Sponsor Name:Laboratorios Dr. Esteve, SA
    Full Title: An evaluation of the dose-response relationship of Cizolirtine citrate 300 mg, twice daily, and 400 mg, twice daily, versus placebo in subjects with urge urinary incontinence. A 12-week, randomised...
    Medical condition: Urge Urinary Incontinence
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-003321-14 Sponsor Protocol Number: TS002 Start Date*: 2019-11-01
    Sponsor Name:Tesla Medical s.r.o.
    Full Title: 12-weeks, Open-label, Randomized, Multicenter, Post Marketing Clinical Follow-up Study to Evaluate Safety, Tolerability and Efficacy of the Home-Based electrical Transcutaneous NeuroModulation (eT...
    Medical condition: Naive Subjects With Overactive Bladder (OAB)
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005546-39 Sponsor Protocol Number: 905-EC-003 Start Date*: 2006-12-11
    Sponsor Name:Astellas Pharma Europe BV
    Full Title: SOLIFENACIN SUCCINATE IN A FLEXIBLE DOSE REGIMEN WITH SIMPLIFIED BLADDER TRAINING VERSUS SOLIFENACIN SUCCINATE IN A FLEXIBLE DOSE REGIMEN ALONE IN A PROSPECTIVE, RANDOMIZED, PARALLEL GROUP, OVERACT...
    Medical condition: Solifenacin succinate is indicated for the relief of symptoms of urinary frequency, nocturia and urgency with or without incontinence, associated with overactive bladder 10059617
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) IE (Completed) HU (Completed) CZ (Completed) GB (Completed) DK (Completed) SE (Completed) IT (Completed) FI (Completed)
    Trial results: View results
    EudraCT Number: 2006-001334-40 Sponsor Protocol Number: PSD506-OAB-005 Start Date*: 2006-09-29
    Sponsor Name:PLETHORA SOLUTIONS LIMITED
    Full Title: A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients symptoms of overactive bladder (OAB)
    Medical condition: overactive bladder (OAB)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Prematurely Ended) GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011418-68 Sponsor Protocol Number: CSO302L Start Date*: 2009-10-14
    Sponsor Name:GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Full Title: Pilotstudie zur Anwendung eines pflanzlichen Kombinationspräparats bei Frauen mit Reizblase ("Overactive Bladder"-Syndrom). (Translation: Pilot-Study with a herbal combination in women suffering f...
    Medical condition: Frequent micturition and urinary urgency, as common in patients suffering from overactive bladder syndrome.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10059617 Overactive bladder LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001210-33 Sponsor Protocol Number: UHL 10054 Start Date*: 2006-06-20
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: A cohort study of anticholinergic drugs in South Asian women with detrusor overactivity
    Medical condition: The medical condidtion is overactive bladder . A wide range of different anticholinergic agents is available to treat overactive bladder (OAB) symptoms. Within the last 15 years, ethno-pharmacologi...
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-005344-15 Sponsor Protocol Number: BOTC3-OAB-01 Start Date*: 2013-03-25
    Sponsor Name:Adyton, s.r.o.
    Full Title: A Double Blind Study Aiming To Evaluate The Efficacy Of Bladder Instillation With Botulinum Toxin (200U) + TC-3 Gel In Comparison To Instillation With Botulinum Toxin (200U) + TC-3 Gel + DMSO, To D...
    Medical condition: Overactive bladder (OAB) syndrome (in women), as defined by the International Continence Society (ICS): severe urgency with or without urge urinary incontinence, usually accompanied with increased ...
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004857 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 05 07:03:22 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA